The Enterprise Value as of December 2025 (TTM) for NuGenerex Immuno-Oncology, Inc. (NUGX) is 11.22M

According to NuGenerex Immuno-Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.22M. This represents a change of -26.43% compared to the average of 15.25M of the last 4 quarters.

NuGenerex Immuno-Oncology, Inc. (NUGX) Historical Enterprise Value (quarterly & annually)

How has NUGX Enterprise Value performed in the past?

The mean historical Enterprise Value of NuGenerex Immuno-Oncology, Inc. over the last ten years is 7.66M. The current 11.22M Enterprise Value has changed 14.54% with respect to the historical average. Over the past ten years (40 quarters), NUGX's Enterprise Value was at its highest in in the January 2019 quarter at 42.81M. The Enterprise Value was at its lowest in in the July 2016 quarter at 1.48M.

NuGenerex Immuno-Oncology, Inc. (NUGX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NuGenerex Immuno-Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NuGenerex Immuno-Oncology, Inc. (NUGX) Average Enterprise Value

How has NUGX Enterprise Value performed in the past?

The current Enterprise Value of NuGenerex Immuno-Oncology, Inc. (NUGX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

NuGenerex Immuno-Oncology, Inc. (NUGX) Enterprise Value vs. Peers

How is NUGX’s Enterprise Value compared to its peers?

NuGenerex Immuno-Oncology, Inc.’s Enterprise Value is greater than Navidea Biopharmaceuticals, Inc. (449.76K), greater than WPD Pharmaceuticals Inc. (706.30K), less than Nanomix Corporation (11.40M), greater than NeonMind Biosciences Inc. (0), less than Gelesis Holdings, Inc. (66.48M), greater than Goodbody Health Limited (-5730945.93), less than Advanzeon Solutions, Inc. (0), greater than Gene Biotherapeutics, Inc. (880.93K), greater than MobileSmith, Inc. (4.87M), less than MagForce AG (29.01M),

Build a custom stock screener for NuGenerex Immuno-Oncology, Inc. (NUGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NuGenerex Immuno-Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NuGenerex Immuno-Oncology, Inc. (NUGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NuGenerex Immuno-Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.